Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection
Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate...
Saved in:
Published in | Endocrine Connections Vol. 10; no. 6; pp. 646 - 655 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Bioscientifica Ltd
17.06.2021
Bioscientifica |
Subjects | |
Online Access | Get full text |
ISSN | 2049-3614 2049-3614 |
DOI | 10.1530/EC-21-0029 |
Cover
Loading…
Abstract | Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design Cohort observational study. Methods We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients. |
---|---|
AbstractList | Objective: Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, w e studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design: Cohort observational study. Methods: We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results: A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of neg ative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions: NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other crit ically ill patients. Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design Cohort observational study. Methods We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients. Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Cohort observational study. We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients. Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients.OBJECTIVEFollowing the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients.Cohort observational study.DESIGNCohort observational study.We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism.METHODSWe measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism.A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare.RESULTSA NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare.NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.CONCLUSIONSNTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients. |
Author | Zacharis, Alexandros Orfanos, Stylianos Diamantopoulos, Aristidis Ampelakiotou, Kleio Koulenti, Marina Tsagarakis, Stylianos Vassiliadi, Dimitra Argyro Gavrielatou, Evdokia Athanasiou, Nicolaos Ilias, Ioannis Pratikaki, Maria Kotanidou, Anastasia Jahaj, Edison Vassiliou, Alice G Detsika, Maria Dimopoulou, Ioanna Manolopoulos, Konstantinos N Tsipilis, Stamatis |
AuthorAffiliation | Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece 2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece |
AuthorAffiliation_xml | – name: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – name: 2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece – name: Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece – name: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – name: Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece – name: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece |
Author_xml | – sequence: 1 givenname: Dimitra Argyro surname: Vassiliadi fullname: Vassiliadi, Dimitra Argyro email: dimitra.vas@gmail.com organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – sequence: 2 givenname: Ioannis surname: Ilias fullname: Ilias, Ioannis organization: Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece – sequence: 3 givenname: Maria surname: Pratikaki fullname: Pratikaki, Maria organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 4 givenname: Edison surname: Jahaj fullname: Jahaj, Edison organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 5 givenname: Alice G surname: Vassiliou fullname: Vassiliou, Alice G organization: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 6 givenname: Maria surname: Detsika fullname: Detsika, Maria organization: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 7 givenname: Kleio surname: Ampelakiotou fullname: Ampelakiotou, Kleio organization: Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece – sequence: 8 givenname: Marina surname: Koulenti fullname: Koulenti, Marina organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – sequence: 9 givenname: Konstantinos N surname: Manolopoulos fullname: Manolopoulos, Konstantinos N organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – sequence: 10 givenname: Stamatis surname: Tsipilis fullname: Tsipilis, Stamatis organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 11 givenname: Evdokia surname: Gavrielatou fullname: Gavrielatou, Evdokia organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 12 givenname: Aristidis surname: Diamantopoulos fullname: Diamantopoulos, Aristidis organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – sequence: 13 givenname: Alexandros surname: Zacharis fullname: Zacharis, Alexandros organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 14 givenname: Nicolaos surname: Athanasiou fullname: Athanasiou, Nicolaos organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 15 givenname: Stylianos surname: Orfanos fullname: Orfanos, Stylianos organization: 2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece – sequence: 16 givenname: Anastasia surname: Kotanidou fullname: Kotanidou, Anastasia organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece – sequence: 17 givenname: Stylianos surname: Tsagarakis fullname: Tsagarakis, Stylianos organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece – sequence: 18 givenname: Ioanna surname: Dimopoulou fullname: Dimopoulou, Ioanna organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34010152$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1rFDEUhoNU7Ie98QdILkUYPckkM5MboQxrLRQEW70N-ZpuSnayJrOV_fdmulvZipibhJP3PG_Ce07R0RhHh9AbAh8Ir-Hjoq8oqQCoeIFOKDBR1Q1hRwfnY3Se8z2U1ZGmq-EVOq4ZECCcniBzu9ym6C1exrQqZKzC5JKafBwz9iM2yU_eqBC2WI0WF_PqoORDwOsiduOU8S8_LfHNxbebqo8_Klq6B2dm0Gv0clAhu_P9foa-f17c9l-q66-XV_3FdaVZx6eqIU1jGzuQgWttLAxEOaaVBdJYK0xnWhCWg9OEM8ZJp0HUbWupqEUNztn6DF3tuDaqe7lOfqXSVkbl5WMhpjupUnl6cHIAzVTLrWo7xxqnhSWDYrwjnHBlrSmsTzvWeqNXzpryw6TCM-jzm9Ev5V18kB1l0AIrgHd7QIo_Ny5PcuWzcSGo0cVNlpRTIWhTt7P07aHXH5OnlIoAdgKTYs7JDdL46TGjYu2DJCDnWZCLXlIi51koLe__anmi_lO852sfs5nT9ENJ-H8tvwGW-sS- |
CitedBy_id | crossref_primary_10_3390_ijerph19138063 crossref_primary_10_3389_fendo_2024_1411262 crossref_primary_10_3390_life12122014 crossref_primary_10_1007_s12020_023_03658_3 crossref_primary_10_3389_fendo_2022_1041676 crossref_primary_10_1038_s41574_023_00946_w crossref_primary_10_3389_fendo_2022_1031188 crossref_primary_10_1007_s12020_022_03264_9 crossref_primary_10_3390_jpm12101703 crossref_primary_10_5812_ijem_146857 crossref_primary_10_3389_fendo_2024_1361479 crossref_primary_10_3389_fendo_2024_1477389 crossref_primary_10_1080_17446651_2022_2099372 crossref_primary_10_3389_fendo_2021_779692 crossref_primary_10_3389_fendo_2022_947594 crossref_primary_10_5662_wjm_v12_i3_99 crossref_primary_10_3390_ijerph19116912 crossref_primary_10_1186_s12917_024_04319_x crossref_primary_10_3389_fendo_2022_840668 crossref_primary_10_1080_07435800_2021_1972307 |
ContentType | Journal Article |
Copyright | The authors The authors 2021 The authors |
Copyright_xml | – notice: The authors – notice: The authors 2021 The authors |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1530/EC-21-0029 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
DocumentTitleAlternate | Thyroid function in SARS-CoV-2 infection D A Vassiliadi et al |
EISSN | 2049-3614 |
EndPage | 655 |
ExternalDocumentID | oai_doaj_org_article_f0b4a75da78e46eb9d1fa4581515addc PMC8240704 34010152 10_1530_EC_21_0029 |
Genre | Journal Article |
GroupedDBID | 53G 5VS AAFZV ABLYK ABSGY ABSQV ADACO ADBBV AIPOO ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV DIK EBS EE- FRJ GROUPED_DOAJ GX1 INIJC KQ8 M48 M~E OK1 RHF RPM TBS AAKMT AAYXX AOIJS BTFSW CITATION F9R H13 PGMZT NPM 7X8 5PM |
ID | FETCH-LOGICAL-b485t-6166d6df1f5bbcd0f1ae4bad016dd9c8c709d50eb1544518b09377d293930eed3 |
IEDL.DBID | M48 |
ISSN | 2049-3614 |
IngestDate | Wed Aug 27 01:24:59 EDT 2025 Thu Aug 21 13:46:15 EDT 2025 Fri Jul 11 01:49:32 EDT 2025 Thu Jan 02 22:56:04 EST 2025 Thu Apr 24 23:03:48 EDT 2025 Tue Jul 01 02:04:29 EDT 2025 Tue Jul 13 02:12:06 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | COVID-19 SARS-CoV-2 thyroid critical illness |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b485t-6166d6df1f5bbcd0f1ae4bad016dd9c8c709d50eb1544518b09377d293930eed3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 D A Vassiliad and I Ilias contributed equally to this work |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1530/EC-21-0029 |
PMID | 34010152 |
PQID | 2529926374 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f0b4a75da78e46eb9d1fa4581515addc pubmedcentral_primary_oai_pubmedcentral_nih_gov_8240704 proquest_miscellaneous_2529926374 pubmed_primary_34010152 crossref_citationtrail_10_1530_EC_21_0029 crossref_primary_10_1530_EC_21_0029 bioscientifica_primary_10_1530_EC_21_0029 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-Jun-17 |
PublicationDateYYYYMMDD | 2021-06-17 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-Jun-17 day: 17 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bristol |
PublicationTitle | Endocrine Connections |
PublicationTitleAlternate | Endocr Connect |
PublicationYear | 2021 |
Publisher | Bioscientifica Ltd Bioscientifica |
Publisher_xml | – name: Bioscientifica Ltd – name: Bioscientifica |
SSID | ssj0000816830 |
Score | 2.2947106 |
Snippet | Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid... Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests... Objective: Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid... |
SourceID | doaj pubmedcentral proquest pubmed crossref bioscientifica |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 646 |
SubjectTerms | covid-19 critical illness sars-cov-2 thyroid |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQTxyogEK7LSAjEFIPVh0_4uS4rLaqOPTQB-rNil_aSItTtdvD_nvGTna1QRVcuDpW4njGnu-zR98g9FU4LoM0nBhjgaDU1pMK7E4EN0lbJhQ-5GyLy_LiVvy4k3c7pb5STlgvD9xP3FmgRjRKukZVXpTe1K4IjZBVCsSwNm3afSHm7ZCpvAenchK50AgDCEw4BKFBm1RyejafEQYkmiZc-cq0vWpkTs0Zh6es4v8c9Pwzg3InJJ2_RvsDlsTT_h_eoBc-vkUH0wg8-tcaf8M5uzMfmx8ge7NYP3StwwsAqV30OF-T98d1uI3YDiUPlmvcRIdjF8lOU7tc4kGB9RGno1t8Pb26JrPuJ2F4k88V36Hb8_nN7IIMBRaIEZVcAW0sS1e6UIC1jHU0FI0XpnEAA52rbWUVrZ2ksJ1nHbPKUAAzygFCqDmF4Mrfoz0Yjz9COFgADsZB-AdCF5QxgYWSU-u8544rM0Gn44nW972ahk4sBIyi5zPNCp2MAn03NtB2UCpPBTOWz_b9su37tzd-T6bc9kia2rkBPE0Pnqb_5WkT9HnjCBrWYLpYaaLvnh41kxDUWcmVmKDD3jG2n-IiqfhJNkFq5DKjsYyfxHaRdb6rxLapOP4fgz9BL1nKxklVl9QHtLd6ePIfAU6tzKe8cn4DYlMfCg priority: 102 providerName: Directory of Open Access Journals |
Title | Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection |
URI | http://dx.doi.org/10.1530/EC-21-0029 https://www.ncbi.nlm.nih.gov/pubmed/34010152 https://www.proquest.com/docview/2529926374 https://pubmed.ncbi.nlm.nih.gov/PMC8240704 https://doaj.org/article/f0b4a75da78e46eb9d1fa4581515addc |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELaWRUJ7AAHLozxWRiAkDmad2ImTA0Kl6rJCggO7Rb1Z8YtWCg60XYn-e8ZOUm1Q4ZJD4iRWZibzjTP5PoReccMylylGlNJQoJTakgLsTjhTgVvGJdbFbosv-fmMf5pn8wPU63d2D3C9t7QLelKzVf3296_tewj4d1G9h9HT6YSkUBPTtLyBbkJGEiFAP3cwP76Rg7hElB1JARATBimpYyodnn6EbjEeSNfCb0i31bKlk4w9O8O8Fen992HSv1srr-Wqs7voTgcy8bj1invowPr76HjsocD-scWvcWz7jOvpx0hfLrarZmnwAtBr4y2O38_bdTy89Fh3Wgj1FlfeYN94cm3Xsq5xR826xmFNF1-Mv16QSfONpLhv9PIP0Oxsejk5J53yAlG8yDZQT-a5yY1LwIxKG-qSynJVGcCHxpS60IKWJqPwno8EZ4WigHKEAehQMgpZlz1EhzAf-xhhpwFRKAO4ACo9J5RyqcsZ1cZaZphQI_Rm-KDlz5ZmQ4byBOwjpxOZJjLYB8b2NpC6ozAPShr13rEvd2P_d8UPwZS7EYFsO-5oVt9lF7vSUcUrkZlKFJbnVpUmcRXPioAFIT3oEXrRO4KE4AxfXCpvm6u1TDPI9mnOBB-hR61j7G7Ve9oIiYHLDOYyPOKXi0gAXoQynPIn_7zmU3SUht6boLEknqHDzerKPgfwtFEncdEBth_nyUmMkj8n6hhR |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thyroid+hormone+alterations+in+critically+and+non-critically+ill+patients+with+SARS-CoV-2+infection&rft.jtitle=Endocrine+Connections&rft.au=Vassiliadi%2C+Dimitra+Argyro&rft.au=Ilias%2C+Ioannis&rft.au=Pratikaki%2C+Maria&rft.au=Jahaj%2C+Edison&rft.date=2021-06-17&rft.issn=2049-3614&rft.eissn=2049-3614&rft.volume=10&rft.issue=6&rft.spage=646&rft_id=info:doi/10.1530%2FEC-21-0029&rft_id=info%3Apmid%2F34010152&rft.externalDocID=34010152 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-3614&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-3614&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-3614&client=summon |